CoChat

Workshop Report: FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant Platforms

Open access
Pang, Li, Sager, Philip, Yang, Xi, Shi, Hong, Sannajust, Frederick, Brock, Mathew, Wu, Joseph C., Abi-Gerges, Najah, Lyn-Cook, Beverly, Berridge, Brian R., Stockbridge, Norman · 2019 · Circulation Research
Cited by 73

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Given that cardiovascular safety concerns remain the leading cause of drug attrition at the preclinical drug development stage, the National Center for Toxicological Research of the US Food and Drug Administration hosted a workshop to discuss current gaps and challenges in translating preclinical cardiovascular safety data to humans. This white paper summarizes the topics presented by speakers from academia, industry, and government intended to address the theme of improving cardiotoxicity assessment in drug development. The main conclusion is that to reduce cardiovascular safety liabilities of new therapeutic agents, there is an urgent need to integrate human-relevant platforms/approaches into drug development. Potential regulatory applications of human-derived cardiomyocytes and future directions in employing human-relevant platforms to fill the gaps and overcome barriers and challenges in preclinical cardiovascular safety assessment were discussed. This paper is intended to serve as an initial step in a public-private collaborative development program for human-relevant cardiotoxicity tools, particularly for cardiotoxicities characterized by contractile dysfunction or structural injury.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circresaha.119.315378

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 73

Metadata

Authors
Pang, L., Sager, P., Yang, X., Shi, H., Sannajust, F., Brock, M., Wu, J. C., Abi-Gerges, N., Lyn-Cook, B., Berridge, B. R., & Stockbridge, N.
Venue
Circulation Research
Published
2019-10-11
Volume
125
Issue
9
Pages
855-867
ISSN
  • 0009-7330 (ISSN-L)
  • 1524-4571
OpenAlex
W2979409238
Cited by
73
References
13
FWCI
10.73
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Workshop Report: FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant Platforms. https://app.cochat.ai/papers/10.1161/circresaha.119.315378
The paper
Pang, L., Sager, P., Yang, X., Shi, H., Sannajust, F., Brock, M., Wu, J. C., Abi-Gerges, N., Lyn-Cook, B., Berridge, B. R., & Stockbridge, N. (2019). Workshop Report: FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant Platforms. Circulation Research. https://doi.org/10.1161/circresaha.119.315378

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.